AI tool aims to stop diabetes medication Mix-Ups after hospital stays
NCT ID NCT07599852
First seen May 27, 2026 · Last updated Jun 19, 2026 · Updated 4 times
Summary
This study tests whether a support program led by a nurse and community health worker can help people with type 2 diabetes manage their medications after leaving the hospital. The program uses an AI tool called MEDBRIDGE to identify high-risk patients and provides 3 months of follow-up care. The goal is to see if the program is practical and acceptable, and to track changes in blood sugar and emergency visits. Forty-five patients will take part at two Alabama hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cooper Green Mercy Health Services
Birmingham, Alabama, 35233, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Alabama at Birmingham
Birmingham, Alabama, 35223, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention
What this could lead to
If this works, it could point toward a practical way to help people with diabetes avoid medication mistakes and hospital readmissions after discharge.
What could go wrong
This is a small, early feasibility study with only 45 participants, so results may not apply to everyone. The program may not improve blood sugar or reduce emergency visits as hoped.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.